Smiths Group Divests Its Medical Division To ICU Medical In $2.4B Deal

  • ICU Medical Inc ICUI has agreed to acquire Smiths Group plc's Medical division in a transaction that will create an IV therapy company and simplify customer workflow. 
  • The Smiths Medical business includes syringe & ambulatory infusion devices, vascular access, and vital care products. 
  • When combined with ICU Medical's existing businesses, the combined entity will generate estimated pro forma revenues of approximately $2.5 billion.
  • Smiths will receive 2.5 million newly issued ICU Medical shares, currently valued at approximately $500 million, and $1.85 billion in cash.
  • Smiths will own approximately 10% of ICU Medical. It is also eligible to receive a contingent earn-out consideration of $100 million in cash.
  • The transaction is expected to close in 1H of 2022. In addition, at closing, a Smiths designee will be appointed to the ICU Medical board of directors.
  • Price Action: ICUI stock closed 1.58% higher at $205.98 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: M&ANewsHealth CareGeneralBriefsDivestitures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!